Sign in
4

Changes in Ownership

Viking Therapeutics, Inc. Filed Acc 0001209191-24-005116

Chief Financial Officer gave up 16,610 shares (to pay taxes)

  • Chief Financial Officer acquired 31,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ZANTE GREG · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-27 Grant or award : show line 1 in the form +31,667 223,971 D
2024-03-27 Shares withheld for taxes : show line 2 in the form −16,610 $83.34 $1,384,277 207,361 D
Loading xslF345X05/doc4.xml…